MedPlus Health Services Limited reported robust financial results for the quarter and year ended March 31, 2026. The company achieved a annual revenue of ₹68,924.66 million and a net profit of ₹2,196.06 million. Alongside these positive fiscal outcomes, the Board has announced key leadership changes, including new director appointments, the reappointment of the Managing Director, and the resignation of the Company Secretary, while gearing up for its 20th Annual General Meeting.
Annual and Quarterly Financial Performance
For the financial year ended March 31, 2026, MedPlus delivered significant growth, recording a total income of ₹69,637.90 million. The company’s annual profit after tax stood at ₹2,196.06 million, marking a notable improvement over the previous year. For the fourth quarter (Jan-Mar 2026), the company generated revenue from operations of ₹18,643.85 million with a quarterly profit of ₹639.73 million. The company’s retail segment remains the primary growth driver, contributing ₹67,601.06 million to the annual segment revenue.
Strategic Board and Leadership Updates
The Board of Directors has initiated a transition in leadership to steer the company’s future strategy. Mr. Gangadi Madhukar Reddy has been reappointed as the Managing Director for a five-year term starting August 3, 2026. Additionally, the company is strengthening its board with the appointment of Mr. Ajit Pandurang Rangnekar and Mr. Mohankrishna Reddy Arvabumi as Non-Executive Independent Directors, effective May 20, 2026.
Conversely, the company notes the tenure completion of Independent Directors Mr. Madhavan Ganesan and Mr. Murali Sivaraman, effective June 10, 2026. Furthermore, Mr. Manoj Kumar Srivastava has resigned from his position as Company Secretary and Compliance Officer.
Corporate Developments
In addition to financial and leadership updates, the company confirmed the allotment of 82,419 equity shares under the Employee Stock Option Plan (ESOP 2021). Looking ahead, MedPlus has scheduled its 20th Annual General Meeting for August 17, 2026, which will be conducted via video conferencing to facilitate shareholder participation.
Source: BSE
